USE OF IMMOBILIZED LIGANDS AND [I125] PROTEIN A FOR IMMUNOASSAYS OF THROMBOXANE-B2, PROSTAGLANDIN-D2, 13,14-DIHYDRO-PROSTAGLANDIN-E2, 5,6-DIHYDRO-PROSTAGLANDIN-I2, 6-KETO-PROSTAGLANDIN-F1-ALPHA, 15-HYDROXY-9-ALPHA, 11-ALPHA (EPOXYMETHANO) PROSTA-5,13-DIENOIC ACID AND 15-HYDROXY-11-ALPHA, 9-ALPHA (EPOXYMETHANO) PROSTA-5, 13-DIENOIC ACIDK

被引：76

作者：

LEVINE, L ^{[1
]}

ALAM, I ^{[1
]}

LANGONE, JJ ^{[1
]}

机构：

[1] NCI,IMMUNOL LAB,BETHESDA,MD 20014

来源：

PROSTAGLANDINS AND MEDICINE | 1979年 / 2卷 / 03期

关键词：

D O I：

10.1016/0161-4630(79)90035-1

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：177 / 189

页数：13

共 7 条

[1] RADIOIMMUNOASSAY OF 11-ALPHA, 15-DIHYDROXY-9-KETO-PROSTA-5, 13-DIENOIC ACID (PROSTAGLANDIN-E2) AND 9-ALPHA, 11-ALPHA, 15-TRIHYDROXYPROSTA-5, 13-DIENOIC ACID (PROSTAGLANDIN-F2-ALPHA) IN HUMAN-PLASMA
LIJNEN, PJ
VERSCHUEREN, LJ
AMERY, AK
BULLETIN DES SOCIETES CHIMIQUES BELGES, 1981, 90 (03): : 229 - 240
[2] STEREOSPECIFIC CONVERSION OF PROSTAGLANDIN-D2 TO (5Z,13E)-(15S)-9-ALPHA,-11-BETA,15-TRIHYDROXYPROSTA-5,13-DIEN-1-OIC ACID (9-ALPHA,11-BETA-PROSTAGLANDIN-F2) AND OF PROSTAGLANDIN-H2 TO PROSTAGLANDIN-F2-ALPHA BY BOVINE LUNG PROSTAGLANDIN-F SYNTHASE
WATANABE, K
IGUCHI, Y
IGUCHI, S
ARAI, Y
HAYAISHI, O
ROBERTS, LJ
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (06) : 1583 - 1587
[3] 6-KETO PROSTAGLANDIN-F-1-ALPHA, THROMBOXANE-B2 AND 13,14-DIHYDRO-15-KETO PROSTAGLANDIN-F LEVELS IN MATERNAL AND FETAL PLASMA
YAMAGUCHI, M
MORI, N
PROSTAGLANDINS LEUKOTRIENES AND MEDICINE, 1984, 15 (03): : 325 - 336
[4] TRANSFORMATION OF PROSTAGLANDIN-D2 TO 9-ALPHA,11B-(15S)-TRIHYDROXYPROSTA-(5Z,13E)-DIEN-1-OIC ACID (9-ALPHA,11-BETA-PROSTAGLANDIN-F2) - A UNIQUE BIOLOGICALLY-ACTIVE PROSTAGLANDIN PRODUCED ENZYMATICALLY INVIVO IN HUMANS
LISTON, TE
ROBERTS, LJ
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (18) : 6030 - 6034
[5] 6-KETO PROSTAGLANDIN-F 1-ALPHA, THROMBOXANE-B2, AND 13,14-DIHYDRO-15-KETO PROSTAGLANDIN-F CONCENTRATIONS OF NORMOTENSIVE AND PREECLAMPTIC PATIENTS DURING PREGNANCY, DELIVERY, AND THE POSTPARTUM PERIOD
YAMAGUCHI, M
MORI, N
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1985, 151 (01) : 121 - 127
[6] (5Z,13E)-(15S)-9-ALPHA,11-BETA,15-TRIHYDROXYPROSTA-5,13-DIEN-1-OIC ACID (9-ALPHA,11-BETA-PROSTAGLANDIN-F2) - FORMATION AND METABOLISM BY HUMAN-LUNG AND CONTRACTILE EFFECTS ON HUMAN BRONCHIAL SMOOTH-MUSCLE
SEIBERT, K
SHELLER, JR
ROBERTS, LJ
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (01) : 256 - 260
[7] PROTECTIVE EFFECTS OF THE NOVEL THROMBOXANE-A2 RECEPTOR ANTAGONIST SODIUM (E)-11-[2-(5,6-DIMETHYL-1-BENZIMIDAZOLYL)-ETHYLIDENE]-6,11-DIHYDRODIBENZ[B,E] OXEPINE-2-CARBOXYLATE MONOHYDRATE AGAINST 9,11-DIDEOXY-9-ALPHA, 11-ALPHA-EPOXYMETHANO-PROSTAGLANDIN-F2-ALPHA-INDUCED SUDDEN-DEATH IN GUINEA-PIGS AND RATS
SHIRAKURA, S
KARASAWA, A
KUBO, K
ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1991, 41-2 (12): : 1242 - 1245

← 1 →